TNFRSF11B and diabetes mellitus: Furthermore, in patients from the South Danish Diabetes Study (n = 371), rosiglitazone treatment for 2 years caused a significant decrease in plasma OPG concentrations while treatment with metformin or insulin did not change OPG [96].